These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23554417)

  • 1. Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.
    Gonzalez D; Schmidt S; Derendorf H
    Clin Microbiol Rev; 2013 Apr; 26(2):274-88. PubMed ID: 23554417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside.
    Bulik CC; Bader JC; Zhang L; Van Wart SA; Rubino CM; Bhavnani SM; Sweeney KL; Ambrose PG
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):161-177. PubMed ID: 28353185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Pharmacodynamics of Antimicrobials in Critically Ill Patients.
    Owen EJ; Gibson GA; Buckman SA
    Surg Infect (Larchmt); 2018; 19(2):155-162. PubMed ID: 29272204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic/pharmacodynamic indices.
    Barbour A; Scaglione F; Derendorf H
    Int J Antimicrob Agents; 2010 May; 35(5):431-8. PubMed ID: 20219329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.
    Li RC; Zhu M; Schentag JJ
    Clin Pharmacokinet; 1999 Jul; 37(1):1-16. PubMed ID: 10451780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The integration of pharmacokinetics and pathogen susceptibility data in the design of rational dosing regimens.
    Maglio D; Nicolau DP
    Methods Find Exp Clin Pharmacol; 2004 Dec; 26(10):781-8. PubMed ID: 15672121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.
    Dudley MN; Ambrose PG
    Curr Opin Microbiol; 2000 Oct; 3(5):515-21. PubMed ID: 11050452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer.
    Theuretzbacher U
    Clin Infect Dis; 2012 Jun; 54(12):1785-92. PubMed ID: 22437238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization.
    Deitchman AN; Heinrichs MT; Khaowroongrueng V; Jadhav SB; Derendorf H
    AAPS J; 2017 Mar; 19(2):334-342. PubMed ID: 27943149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdialysis. A novel tool for clinical studies of anti-infective agents.
    Joukhadar C; Derendorf H; Müller M
    Eur J Clin Pharmacol; 2001 Jun; 57(3):211-9. PubMed ID: 11497336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial tissue concentrations.
    Liu P; Derendorf H
    Infect Dis Clin North Am; 2003 Sep; 17(3):599-613. PubMed ID: 14711079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics/pharmacodynamics characterization of combined antimicrobial agents: a real challenge and an urgent need.
    Couet W
    Clin Microbiol Infect; 2018 Jul; 24(7):687-688. PubMed ID: 29649606
    [No Abstract]   [Full Text] [Related]  

  • 15. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.
    Martinez MN; Papich MG; Drusano GL
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2795-805. PubMed ID: 22371890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of pharmacokinetics and pharmacodynamics of antimicrobial agents.
    Estes L
    Mayo Clin Proc; 1998 Nov; 73(11):1114-22. PubMed ID: 9818049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PK/PD analysis and proper dosage of antimicrobial agents for effective and safe treatment of infectious diseases].
    Hori S
    Yakugaku Zasshi; 2007 Jun; 127(6):931-7. PubMed ID: 17541242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Morbid Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs: Reappraisal Using Recent Case Studies-Issues, Dosing Implications, and Considerations.
    Srinivas NR
    Am J Ther; 2018; 25(2):e224-e246. PubMed ID: 26766291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
    Aliabadi FS; Lees P
    J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs.
    Mouton JW; Dudley MN; Cars O; Derendorf H; Drusano GL
    Int J Antimicrob Agents; 2002 Apr; 19(4):355-8. PubMed ID: 11978507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.